Health Service DG sued for promoting substandard drugs
A drug manufacturer and distributor has filed an application by way of a public interest litigation seeking a direction from the Supreme Court the Bribery Commission to initiate an investigation against Director General of Health Services for promoting substandard drugs and allegedly accumulating wealth.